Abstract
To the Editor,
The exact time to stop bladder cancer patient’s follow-up is not well known and there is not a clear recommendation on if and when stop to follow a patient managed for muscle invasive bladder cancer (MIBC). Major urological guidelines do not provide a precise indication on the timing of follow-up, and there is currently no real consensus on optimal time schedule [...].
Reference13 articles.
1. Muscle-invasive and Metastatic Bladder Cancer - FOLLOW-UP - Uroweb. Accessed May 29, 2022. https://uroweb.org/guidelines/muscle-invasive-and-metastatic-bladder-cancer/chapter/followup
2. Treatment of Non-Metastatic Muscle-Invasive Bladder Cancer: AUA/ASCO/ASTRO/SUO Guideline (Amended 2020) - American Urological Association. Accessed May 29, 2022. https://www.auanet.org/guidelines/guidelines/bladder-cancer-non-metastatic-muscle-invasive-guideline
3. Matsumoto K, Kikuchi E, Horiguchi Y, et al. Late recurrence and progression in non-muscle-invasive bladder cancers after 5-year tumor-free periods. Urology. 2010; 75:1385-1390.
4. Yoo SH, Kim H, Kwak C, Kim HH, Jung JH, Ku JH. Late recurrence of bladder cancer following radical cystectomy: characteristics and outcomes. Urol Int. 2019; 103:291-296.
5. Hautmann RE, Volkmer B, Egghart G, et al. Functional outcome and complications following Ileal neobladder reconstruction in male patients without tumor recurrence. More than 35 years of experience from a single center. J Urol. 2021; 205:174-182.